Transcription of Olanzapine 2.5 mg tablets Olanzapine 5 mg tablets ...
{{id}} {{{paragraph}}}
UKPAR Olanzapine mg, 5 mg, mg, 10 mg, 15 mg and 20 mg tablets PL 32854/0015-20 1 Olanzapine mg tablets Olanzapine 5 mg tablets Olanzapine mg tablets Olanzapine 10 mg tablets Olanzapine 15 mg tablets Olanzapine 20 mg tablets ( Olanzapine ) PL 32854/0015-20 UK Public Assessment Report TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 14 Steps taken after authorisation Page 15 Summary of Product Characteristics Page 16 Product Information Leaflet Page 30 Labelling Page 36 UKPAR Olanzapine mg, 5 mg, mg, 10 mg, 15 mg and 20 mg tablets PL 32854/0015-20 2 Olanzapine mg, 5 mg, mg, 10 mg, 15 mg and 20 mg tablets ( Olanzapine ) PL 32854/0015-20 LAY SUMMARY The Medicines and Healthcare products Regulatory Agency (MHRA) granted Galenicum Health Marketing Authorisations (licences) for the medicinal products Olanzapine mg, 5 mg, mg, 10 mg, 15 mg and 20 mg tablets (PL 32854/0015-20) on 4th July 2011.
UKPAR Olanzapine 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg tablets PL 32854/0015-20 1 Olanzapine 2.5 mg tablets Olanzapine 5 mg tablets Olanzapine 7.5 …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}